Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...

The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...

Although the drugs help me shift unhealthy weight, I was then presented with an unexpected side effect, writes Charlotte ...

U.S.-listed shares of Novo Nordisk declined in the opening minutes of trading Friday on the surprise news that CEO Lars ...

The boss of Ozempic maker Novo Nordisk lost his job yesterday after its share price plunged amid intensifying competition in the multi-billion pound fat jab market. Lars Fruergaard Jorgensen is being ...

It’s the end of an era at Novo Nordisk as longtime CEO Lars Fruergaard Jørgensen—who recently shepherded the company through ...

Over Lars Fruergaard Jørgensen's eight years as CEO, Novo’s sales, profits and share price have almost tripled, the company ...

Novo Nordisk NVO shares have gained 13.9% in the past month. Several factors related to the company’s pipeline, regulatory ...

Joe Edwards is a Live News Reporter based in Newsweek's London Bureau. He covers topics related to weather, climate, and extreme weather events. Joe joined Newsweek in April 2024 after graduating ...